Abstract Details
|
Jorg Dietrich, MD, PhD, FAAN
PRESENTER |
Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceuticals. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Dietrich has received publishing royalties from a publication relating to health care. |
| Duangnapa Roongpiboonsopit, MD (Naresuan UniversityDepartment of Medicine, Faculty of Medicine) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Antreas Charidimou, MD, PhD MSc | Dr. Charidimou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care. Dr. Charidimou has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Journal of Neurological Sciences. |
| No disclosure on file | |
| No disclosure on file | |
| Sergi Martinez-Ramirez, MD (Massachusetts General Hospital) | Dr. Martinez-Ramirez has nothing to disclose. |
| Helen Shih (MGH) | No disclosure on file |
| Anand Viswanathan, MD (Massachusetts General Hospital) | Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. |